Douglas Marks, MD
Hematology/oncology in Mineola, NY
About Dr. Douglas Marks
Dr. Douglas Marks is a physician specializing in hematology/oncology practicing in Mineola, NY, a graduate of Icahn School of Medicine at Mount Sinai (2012). Records list 4 practice addresses. Affiliated with NYU Langone Hospitals, Vns of Ny Home Care Chha. Treated 349 Medicare patients in 2024.
| Specialty | Hematology/oncologyOther hematology/oncology doctors in Mineola |
|---|---|
| Credentials | MD |
| Education | Icahn School of Medicine at Mount Sinai, 2012CMS Doctors and Clinicians |
| Gender | Male |
| NPI number | 1083980189National Provider Identifier (CMS NPPES), issued March 2012 |
| Medicare | Enrolled in Medicare; accepts Medicare assignment (the Medicare-approved amount as full payment)CMS Doctors and Clinicians |
| Telehealth | Offers telehealth servicesCMS Doctors and Clinicians |
Where Dr. Douglas Marks practices
- New York University 259 1st St, Mineola, NY 11501 Directions · group of 6,239 clinicians
- NYU Faculty Group Practice 111 Broadway, New York, NY 10006 (212) 263-9700 · Directions · group of 6,239 clinicians
- Advanced Pulmonary Diagnostics, Rllp 297 Mineola Blvd, Mineola, NY 11501 (516) 294-1377 · Directions · group of 6,239 clinicians
- NYU Breast and Surgical Oncology Associates 160 E 34th St, New York, NY 10016 (212) 263-7300 · Directions · group of 6,239 clinicians
Addresses from CMS Doctors and Clinicians (Medicare enrollment). Call before visiting: a clinician may not see patients at every listed address.
Dr. Douglas Marks' specialties and state licenses
| Specialty (NPPES) | License |
|---|---|
| Hematology & Oncology Primary | NY 274527 |
As reported by the clinician to the NPPES registry. Confirm a license and any disciplinary history with the state medical or licensing board.
Hospital affiliations of Dr. Douglas Marks
- NYU Langone HospitalsHospital · New York, NY
- Vns of Ny Home Care ChhaHome health agency · New York, NY
CMS Facility Affiliation data: facilities where the clinician bills Medicare.
Dr. Douglas Marks' Medicare patients and services (2024)
Most frequent services
| Service | Times | Avg. Medicare allowed |
|---|---|---|
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 590 | $145 |
| Insertion of needle into vein for collection of blood sample | 260 | $8.65 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 91 | $103.55 |
| Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more | 80 | $199.32 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 48 | $86.23 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 35 | $146.34 |
| New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more | 25 | $240.22 |
Common conditions among these patients
Medicare Part B fee-for-service claims only (CMS Medicare Physician & Other Practitioners, 2024). Patients with private insurance or Medicare Advantage are not counted; small counts are suppressed by CMS. This describes the patients, not the quality of care.
Dr. Douglas Marks' Medicare quality score (MIPS 2024)
The Merit-based Incentive Payment System scores clinicians who bill Medicare. Reported as group. Source: CMS Care Compare, PY 2024 clinician public reporting.
Payments from drug and device companies to Dr. Douglas Marks (2025)
$9,543.13 in 20 general payments reported in 2025.
| Type | Payments | Amount |
|---|---|---|
| Consulting fees | 6 | $8,415 |
| Food and beverage | 12 | $961.47 |
| Long-term medical supply or device loans | 2 | $166.66 |
Paying companies: Stemline Therapeutics Inc. ($4,700.98), AstraZeneca Pharmaceuticals LP ($3,830), Daiichi Sankyo Inc. ($804.88), NOVARTIS PHARMACEUTICALS CORPORATION ($207.27).
Reported by companies under the federal Open Payments program (CMS, program year 2025). A payment, such as a meal at an educational event, does not mean wrongdoing; clinicians can dispute records with CMS.
Questions about Dr. Douglas Marks
What kind of clinician is Dr. Douglas Marks?
Dr. Douglas Marks is listed as a physician specializing in hematology/oncology.
Where does Dr. Douglas Marks practice?
New York University at 259 1st St, Mineola, NY 11501, and 3 other addresses in the records.
What is the office phone number for Dr. Douglas Marks?
The listed office number is (212) 263-9700. Call to confirm availability and whether new patients are accepted.
What is the NPI number of Dr. Douglas Marks?
The National Provider Identifier is 1083980189.
Does Dr. Douglas Marks accept Medicare?
Yes. CMS lists this clinician as accepting Medicare assignment. Confirm your plan with the office.
Which hospitals is Dr. Douglas Marks affiliated with?
NYU Langone Hospitals, Vns of Ny Home Care Chha.
Where did Dr. Douglas Marks go to medical school?
Icahn School of Medicine at Mount Sinai, graduating in 2012.
Where this information comes from
| CMS Doctors and Clinicians | Name, specialty, education, Medicare enrollment and practice addresses.Centers for Medicare & Medicaid Services, national downloadable file (2026) |
|---|---|
| NPPES NPI registry | NPI, specialties (taxonomy) and state licenses.CMS National Plan and Provider Enumeration System; record updated 2021-02-23 |
| Facility affiliations | Hospitals and other facilities.CMS Doctors and Clinicians facility affiliation file; names from CMS Provider of Services |
| Medicare utilization | Patients, services and conditions.CMS Medicare Physician & Other Practitioners, 2024 |
| MIPS | Quality payment program scores.CMS clinician public reporting, PY 2024 |
| Open Payments | Payments from drug and device companies.CMS Open Payments, program year 2025 |
Information is public record and may lag behind changes. Clinicians update it through NPPES and Medicare PECOS. See something wrong? Tell us.